Pricing Log in Create free account

KALA BIO, Inc. (KALA) vs Nuvilex Inc. (PMCB)

KALA BIO, Inc. and Nuvilex Inc. are both Biotechnology companies. KALA BIO, Inc. and Nuvilex Inc. are of similar size ($3.8M and $3.7M). KALA BIO, Inc. grew revenue faster over the last twelve months: −50.5% against −71.1%. Across the 11 metrics below, Nuvilex Inc. leads on 6 and KALA BIO, Inc. on 5.

Valuation

Metric KALA PMCB Biotechnology median
P/E n/m n/m 8.50
P/S 0.00 n/m 9.71
P/B 0.00 0.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 3.82 0.64
EV/Sales 7.52 n/m 9.21
Earnings yield (16,821.05%) (679.41%) (33.15%)
Free cash flow yield (141,601.65%) (290.03%) (25.50%)

Profitability

Metric KALA PMCB Biotechnology median
Gross margin 0.00% 95.64% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (345.32%) (58.04%) (56.36%)
Return on assets (43.23%) (50.43%) (48.04%)
Return on invested capital (722.69%) 0.00% 0.00%

Growth

Metric KALA PMCB Biotechnology median
Revenue growth (TTM) (50.54%) (71.06%) 6.02%
EPS growth (last fiscal year) 67.39% (186.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KALA PMCB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.88 40.29 4.72
Net debt to EBITDA 0.19 5.41 0.96

Dividend

Metric KALA PMCB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KALA PMCB Biotechnology median
Market cap 3.72m 3.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack